State-of-the-Art Mass Spectrometry Facility Advances Injury Biomarker Detection
8 Sept 2016
Find out how scientists at the Mass Spectrometry Center, University of Maryland (A Waters Center of Innovation), are using state-of-the-art facilities for drug discovery and development worldwide. Hear how the methods developed in the laboratory using instruments including the Waters’ SYNAPT G2-S mass spectrometer and MSE technology are helping to identify injury-related biomarkers that can be used in the development of therapeutics.
About the company
SelectScience
Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.
Related products
Request Quote for All Products
SYNAPT G2-Si MS
WatersTransform your lab's discovery capability with the SYNAPT G2-Si MS. Information. Informatics. Impact. SYNAPT enables extensive characterization of complex mixtures and molecules with uncompromising qualitative and quantitative performance, streamlined workflows and unparalleled platform versatility. With the SYNAPT G2-Si you get ultimate UPLC/MS/MS performance, powerful data independent & data dependant solutions, CID and ETD fragmentation capabilities, and a wide range of experimental options.
